The biochip market size is calculated at USD 14.37 billion in 2025 and is expected to reach around USD 42.15 billion by 2034, ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

DNA microarray-based gene expression studies of the model organism Saccharomyces cerevisiae have yielded a large amount of genome-wide data concerning the cell cycle, various growth conditions and ...

Pregnancy loss affects up to 25% of pregnancies. New studies using optical genome mapping reveal genetic and fragile-site ...

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or ...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about ...

Microarray testing can only be performed on an amniocentesis or CVS. These tests are more advanced than NIPT and are capable of looking at chromosomes to find out if any of them are missing a small ...